AMBOSS is a powerful learning and clinical decision-support tool striving to empower physicians across the globe to provide the best possible care. Since our launch in 2012, we’ve used cutting-edge technology to revolutionize the way physicians and trainees acquire and apply the latest in scientific knowledge, thereby benefiting patients everywhere.
By 2017, we transformed the learning experience for 95% of the German market and launched our international platform. In 2019, our hard work secured €30M in Series B funding to expand our products and their reach. Today, we continue to find new ways to innovate and establish ourselves to make a global impact. After being named a Top 10 Health & Science company to watch in 2021 by Business Punk, it is clear that we are not the only ones who are excited about the future of AMBOSS.